Multisystem Complications of Type 2 Diabetes: A Comprehensive Narrative Review
IFR Journal of Medical Science and Case Report · 19.09.2025 · 1 (3) · 70-74
DOI: 10.70146/mscrv01i03.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift IFR Journal of Medical Science and Case Report, erschienen am 19.09.2025. Verfasst von Jayakrishnan B. und 4 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) is a worldwide health dilemma that is defined by insulin resistance, defective insulin secretion, and long-term hyperglycemia. Aside from glycemic derangements, T2DM is responsible for a broad array of multisystem complications that markedly enhance morbidity and mortality.
Methods
A narrative synthesis was carried out across PubMed, Scopus, and Web of Science databases with papers from 2000 to 2025. English peer-reviewed papers on systemic complications and treatment approaches in T2DM were considered. Data were synthesized at a thematic level to emphasize pathophysiological mechanisms and changing management strategies.
Results
Results show that cardiovascular disease continues to be the leading cause of mortality in T2DM, propelled by endothelial dysfunction, atherosclerosis, and oxidative stress. Renal complications have a stepwise progression from microalbuminuria to end-stage renal disease, whereas neuropathy and retinopathy are key microvascular loads. Hepatic presentation, especially non-alcoholic fatty liver disease, also commonly occurs with T2DM and hastens systemic complications. Comparative evidence indicates that incretin-based treatments, GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT2 inhibitors have both glycemic control and additional-glycemic effects like weight loss and cardiovascular protection, which are above conventional approaches like intensive insulin treatment.
Conclusion
T2DM is a systemic condition that demands management approaches beyond glucose control. The incorporation of therapies aimed at cardiovascular, renal, and metabolic risk factors provides a more holistic strategy for long-term results. Therapeutic paradigms of the future will have to focus on personalized care that tackles both pathophysiologic defects and multisystem complications.
Zitieren
APA
B., J., Gohil, A. R., S., B., Dhanekula, S. C. V., & Bhojak, N. (2025). Multisystem Complications of Type 2 Diabetes: A Comprehensive Narrative Review. IFR Journal of Medical Science and Case Report, 1(3), 70-74. https://doi.org/10.70146/mscrv01i03.010
Vancouver
B. J, Gohil AR, S. B, Dhanekula SCV, Bhojak N. Multisystem Complications of Type 2 Diabetes: A Comprehensive Narrative Review. IFR Journal of Medical Science and Case Report. 2025;1(3):70-74. doi:10.70146/mscrv01i03.010
BibTeX
@article{B2025,
author = {B., Jayakrishnan and Gohil, Aastha Rameshbhai and S., Binny and Dhanekula, Sankar Chandra Vadan and Bhojak, Narendar},
title = {Multisystem Complications of Type 2 Diabetes: A Comprehensive Narrative Review},
journal = {IFR Journal of Medical Science and Case Report},
year = {2025},
volume = {1},
number = {3},
pages = {70--74},
doi = {10.70146/mscrv01i03.010}
}
EUVIMED